K_&_K_HEALTHCARE_LIMITED - Accounts


Company Registration No. 06454118 (England and Wales)
K & K HEALTHCARE LIMITED
UNAUDITED ABBREVIATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2016
K & K HEALTHCARE LIMITED
CONTENTS
Page
Abbreviated balance sheet
1
Notes to the abbreviated accounts
2 - 4
K & K HEALTHCARE LIMITED
ABBREVIATED BALANCE SHEET
AS AT
31 JULY 2016
31 July 2016
- 1 -
2016
2015
Notes
£
£
£
£
Fixed assets
Intangible assets
2
360,349
390,378
Tangible assets
2
924,012
950,289
Investments
2
150
150
1,284,511
1,340,817
Current assets
Stocks
78,295
87,294
Debtors
520,870
371,530
Cash at bank and in hand
5,607
119,053
604,772
577,877
Creditors: amounts falling due within one year
3
(553,704)
(484,140)
Net current assets
51,068
93,737
Total assets less current liabilities
1,335,579
1,434,554
Creditors: amounts falling due after more than one year
4
(704,725)
(870,488)
Provisions for liabilities
(13,181)
(13,766)
617,673
550,300
Capital and reserves
Called up share capital
5
200
200
Profit and loss account
617,473
550,100
Shareholders' funds
617,673
550,300
For the financial year ended 31 July 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
Approved by the Board for issue on 26 January 2017
Mr S Kotecha
Director
Company Registration No. 06454118
K & K HEALTHCARE LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 JULY 2016
- 2 -
1
Accounting policies
1.1
Accounting convention

The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

1.2
Compliance with accounting standards
The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).
1.3
Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.
1.4
Goodwill
Acquired goodwill is written off in equal annual instalments over its estimated useful economic life which the directors believe is 20 years for pharmacy goodwill and 3 years for other goodwill.
1.5
Tangible fixed assets and depreciation

Tangible fixed assets include investment properties valued by the directors on an existing use open market value basis. Other tangible fixed assets other than freehold land are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:the directors on an existing use open market value basis. Other tangible fixed assets other than freehold land are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Land and buildings Freehold
20 years straight line basis.
Land and buildings Leasehold
Over the life of the lease.
Fixtures, fittings & equipment
5-10 years straight line basis.
Motor vehicles
25% per annum on cost.

Investment properties are included in the balance sheet at their open market value. Depreciation is provided only on those investment properties which are leasehold and where the unexpired lease term is less than 20 years.

 

Although this accounting policy is in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015), it is a departure from the general requirement of the Companies Act 2006 for all tangible assets to be depreciated. In the opinion of the directors compliance with the standard is necessary for the financial statements to give a true and fair view. Depreciation or amortisation is only one of many factors reflected in the annual valuation and the amount of this which might otherwise have been charged cannot be separately identified or quantified.

1.6
Investments
Fixed asset investments are stated at cost less provision for diminution in value.
1.7
Deferred taxation
Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes.  The deferred tax balance has not been discounted.
1.8
Group accounts
The financial statements present information about the company as an individual undertaking and not about its group. The company and its subsidiary undertaking comprise a small-sized group. The company has therefore taken advantage of the exemptions provided by section 399 of the Companies Act 2006  not to prepare group accounts.
K & K HEALTHCARE LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2016
- 3 -
2
Fixed assets
Intangible assets
Tangible assets
Investments
Total
£
£
£
£
Cost
At 1 August 2015
687,256
1,171,666
150
1,859,072
Additions
-
22,428
-
22,428
Disposals
-
(9,864)
-
(9,864)
At 31 July 2016
687,256
1,184,230
150
1,871,636
Depreciation
At 1 August 2015
296,878
221,377
-
518,255
On disposals
-
(7,418)
-
(7,418)
Charge for the year
30,029
46,259
-
76,288
At 31 July 2016
326,907
260,218
-
587,125
Net book value
At 31 July 2016
360,349
924,012
150
1,284,511
At 31 July 2015
390,378
950,289
150
1,340,817
Holdings of more than 20%
The company holds more than 20% of the share capital of the following companies:
Company
Country of registration or
Shares held
incorporation
Class
%
Subsidiary undertakings
Belgrave Pharmacy Limited
England
Ordinary
100.00
Other significant interests
Medicine Support Limited
England
Ordinary
50.00
The aggregate amount of capital and reserves and the results of these undertakings for the last relevant financial year were as follows:
Capital and reserves
Profit/(loss) for the year
2016
2016
Principal activity
£
£
Belgrave Pharmacy Limited
Dormant company
100
-
Medicine Support Limited
Consultancy services
10,036
3,155
K & K HEALTHCARE LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2016
- 4 -
3
Creditors: amounts falling due within one year
The aggregate amount of creditors for which security has been given amounted to £242,189 (2015 - £161,497).
4
Creditors: amounts falling due after more than one year
2016
2015
£
£
Analysis of loans repayable in more than five years
Total amounts repayable by instalments which are due in more than five years
259,293
395,181
The aggregate amount of creditors for which security has been given amounted to £704,725 (2015 - £870,488).
5
Share capital
2016
2015
£
£
Allotted, called up and fully paid
200 Ordinary shares of £1 each
200
200
6
Related party relationships and transactions
Loans to directors
Transactions in relation to loans with directors during the year are outlined in the table below:
Description
% Rate
Opening Balance
Amounts Advanced
Interest Charged
Amounts Repaid
Closing Balance
£
£
£
£
£
Mr S Kotecha - Director's current account
3.00
34,894
94,015
2,246
80,418
50,737
34,894
94,015
2,246
80,418
50,737
2016-07-312015-08-01falsetruetruetruetruetruetmp984D.html2017-01-26064541182015-08-012016-07-31064541182016-07-31064541182015-07-31064541182015-07-3106454118uk-bus:ChiefExecutive2015-08-012016-07-3106454118uk-gaap:LandBuildings2015-08-012016-07-3106454118uk-gaap:LandBuildingsuk-gaap:LeasedTangibleFixedAssets2015-08-012016-07-3106454118uk-gaap:FixturesFittingsToolsEquipment2015-08-012016-07-3106454118uk-gaap:MotorVehicles2015-08-012016-07-3106454118uk-gaap:Subsidiary12015-08-012016-07-3106454118uk-gaap:Subsidiary12016-07-3106454118uk-bus:OrdinaryShareClass12015-08-012016-07-3106454118uk-bus:OrdinaryShareClass12016-07-3106454118uk-bus:OrdinaryShareClass12015-07-31xbrli:purexbrli:sharesiso4217:GBP